Mspa3.Sa
MSPA3.SA operates in the specialty chemicals industry, producing and selling chemical products for industrial applications.
Business. MSPA3.SA operates in the specialty chemicals industry, producing and selling chemical products for industrial applications.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
MSPA3.SA operates in the specialty chemicals industry, producing and selling chemical products for industrial applications.
MSPA3.SA has a liquidity position that is marginally stable, with a current ratio of 1.1, indicating that it has just enough current assets to cover its current liabilities. However, the company's free cash flow is negative at -116.9 million BRL, and capital expenditures are significant at -97.1 million BRL, suggesting that the company is investing heavily in its operations. The company's cash and equivalents amount to 27.6 million BRL, which is insufficient to cover its long-term debt of 206.8 million BRL, resulting in a net cash position that is negative after subtracting total debt.
In terms of profitability, the company is currently unprofitable, with a net loss of 32.7 million BRL and an operating loss of 13.1 million BRL. The return on equity is -4.03%, and the return on assets is -2.28%, both of which are negative and indicate poor performance relative to its equity and asset base. These metrics are below the industry median for specialty chemicals, which typically have positive returns and higher operating margins.
The company's revenue is concentrated in a single entity, as no segment or geographic breakdown is provided in the available data. This lack of diversification could pose a risk if the company's primary market or customer base experiences a downturn. The absence of segment data also limits the ability to assess the performance of different parts of the business.
The company's growth trajectory is uncertain, as there is no outlook data provided for the current or next fiscal year. The negative operating and net income suggest that the company may be facing challenges in maintaining or growing its revenue. The capital expenditures indicate that the company is investing in its operations, which could be a sign of future growth, but the negative free cash flow suggests that these investments are not yet generating positive returns.
The risk assessment indicates that the company has a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting that the company may need to raise additional capital or refinance its debt in the near future. The low dilution risk implies that the company is not expected to issue a significant number of new shares in the near term, which is a positive sign for existing shareholders.
Recent events and filings have not been disclosed in the available data, so there is no information on any recent strategic moves, regulatory changes, or other factors that could impact the company's performance. The absence of recent events makes it difficult to assess the company's current strategic direction and potential for future growth.
- The company is currently unprofitable with negative returns on equity and assets.
- The liquidity position is marginally stable, but the free cash flow is negative.
- The company's revenue is not diversified, posing a concentration risk.
- The company is investing in capital expenditures, but the returns are not yet positive.
- The risk assessment indicates medium liquidity risk and low dilution risk.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- MSPA3.SA Market data — financials · 2026-05-28